HONORE GORMLEY: Open Payments
NPI 1487663118 · MERIDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 47 payments from 11 companies in 2025. Trend: 2023 $666 · 2024 $1,106 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $303 |
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Amgen Inc. | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Viatris Specialty LLC | 1 | $29 |
| GENZYME CORPORATION | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: NUCALA, TEZSPIRE, TRELEGY ELLIPTA, DUPIXENT, ACTHAR, CUVITRU, BREZTRI, YUPELRI.
Industry payments across CT — which companies pay providers there.
